02162.HK
Keymed Biosciences Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 72.05
−1.23%Next report
Analyst consensus
- Next report date
- Mar 30, 2027
- EPS estimate
- -HKD 0.65
- Revenue estimate
- HKD 649.7M
Latest reported
- Last report date
- Aug 19, 2026
- EPS actual
- HKD 4.95
- EPS estimate
- HKD 5.31
- Revenue actual
- HKD 712.2M
- Revenue estimate
- HKD 710.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -6.8%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 19, 2026 | HKD 5.31 | HKD 4.95 | Miss -6.78% | HKD 712.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 30, 2027